Literature DB >> 26377910

Phosphorylation of the N-methyl-d-aspartate receptor is increased in the nucleus accumbens during both acute and extended morphine withdrawal.

Ethan M Anderson1, Turi Reeves2, Katherine Kapernaros2, John K Neubert2, Robert M Caudle2.   

Abstract

Opioid withdrawal causes a dysphoric state that can lead to complications in pain patients and can propagate use in drug abusers and addicts. Opioid withdrawal changes the activity of neurons in the nucleus accumbens, an area rich in both opioid-binding mu opioid receptors and glutamate-binding NMDA receptors. Because the accumbens is an area important for reward and aversion, plastic changes in this area during withdrawal could alter future behaviors in animals. We discovered an increase in phosphorylation of serine 897 in the NR1 subunit of the NMDA receptor (pNR1) during acute morphine withdrawal. This serine can be phosphorylated by protein kinase A (PKA) and dephosphorylated by calcineurin. We next demonstrated that this increased pNR1 change is associated with an increase in NR1 surface expression. NR1 surface expression and pNR1 levels during acute withdrawal were both reduced by the NMDA receptor antagonist MK-801 (dizocilpine hydrogen maleate) and the PKA inhibitor H-89(N-[2-[[3-(4-bromophenyl)-2-propenyl]amino]ethyl]-5-isoquinolinesulfonamide dihydrochloride hydrate). We also found that pNR1 levels remained high after an extended morphine withdrawal period of 2 months, correlated with reward-seeking behavior for palatable food, and were associated with a decrease in accumbal calcineurin levels. These data suggest that NR1 phosphorylation changes during the acute withdrawal phase can be long lasting and may reflect a permanent change in NMDA receptors in the accumbens. These altered NMDA receptors in the accumbens could play a role in long-lasting behaviors associated with reward and opioid use.
Copyright © 2015 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26377910      PMCID: PMC4658487          DOI: 10.1124/jpet.115.227629

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  60 in total

Review 1.  NMDA receptor subunits: diversity, development and disease.

Authors:  S Cull-Candy; S Brickley; M Farrant
Journal:  Curr Opin Neurobiol       Date:  2001-06       Impact factor: 6.627

2.  Activity-dependent mRNA splicing controls ER export and synaptic delivery of NMDA receptors.

Authors:  Yuanyue Mu; Takeshi Otsuka; April C Horton; Derek B Scott; Michael D Ehlers
Journal:  Neuron       Date:  2003-10-30       Impact factor: 17.173

Review 3.  Activity-induced changes of spine morphology.

Authors:  Irina Nikonenko; Pascal Jourdain; Stefano Alberi; Nicolas Toni; Dominique Muller
Journal:  Hippocampus       Date:  2002       Impact factor: 3.899

4.  Rapid CB1 cannabinoid receptor desensitization defines the time course of ERK1/2 MAP kinase signaling.

Authors:  Tanya L Daigle; Christopher S Kearn; Ken Mackie
Journal:  Neuropharmacology       Date:  2007-06-26       Impact factor: 5.250

5.  The mu-opioid receptor and the NMDA receptor associate in PAG neurons: implications in pain control.

Authors:  María Rodríguez-Muñoz; Pilar Sánchez-Blázquez; Ana Vicente-Sánchez; Esther Berrocoso; Javier Garzón
Journal:  Neuropsychopharmacology       Date:  2011-08-03       Impact factor: 7.853

6.  Chronic morphine treatment alters NMDA receptor-mediated synaptic transmission in the nucleus accumbens.

Authors:  G Martin; S H Ahmed; T Blank; J Spiess; G F Koob; G R Siggins
Journal:  J Neurosci       Date:  1999-10-15       Impact factor: 6.167

7.  NMDA receptor phosphorylation at a site affected in schizophrenia controls synaptic and behavioral plasticity.

Authors:  Bo Li; Nino Devidze; Denis Barengolts; Naseem Prostak; Eleana Sphicas; Alfonso J Apicella; Roberto Malinow; Effat S Emamian
Journal:  J Neurosci       Date:  2009-09-23       Impact factor: 6.167

8.  Dopamine D1 receptors mediate CREB phosphorylation via phosphorylation of the NMDA receptor at Ser897-NR1.

Authors:  Joshua T Dudman; Molly E Eaton; Anjali Rajadhyaksha; Wendy Macías; Muffadal Taher; Amy Barczak; Kimihiko Kameyama; Richard Huganir; Christine Konradi
Journal:  J Neurochem       Date:  2003-11       Impact factor: 5.372

9.  Morphine withdrawal decreases responding reinforced by sucrose self-administration in progressive ratio.

Authors:  Dengke Zhang; Xuhui Zhou; Xuyi Wang; Xiaojun Xiang; Hongxian Chen; Wei Hao
Journal:  Addict Biol       Date:  2007-06       Impact factor: 4.280

10.  Effects of mu- and kappa-2 opioid receptor agonists on pain and rearing behaviors.

Authors:  John K Neubert; Heather L Rossi; Jonathan Pogar; Alan C Jenkins; Robert M Caudle
Journal:  Behav Brain Funct       Date:  2007-09-20       Impact factor: 3.759

View more
  7 in total

Review 1.  Do specific NMDA receptor subunits act as gateways for addictive behaviors?

Authors:  F W Hopf
Journal:  Genes Brain Behav       Date:  2016-11-18       Impact factor: 3.449

2.  IL-4 mediated by HSV vector suppresses morphine withdrawal response and decreases TNFα, NR2B, and pC/EBPβ in the periaqueductal gray in rats.

Authors:  H Yi; T Iida; S Liu; D Ikegami; Q Liu; A Iida; D A Lubarsky; S Hao
Journal:  Gene Ther       Date:  2017-03-16       Impact factor: 5.250

Review 3.  Roles of Phosphorylation of N-Methyl-D-Aspartate Receptor in Chronic Pain.

Authors:  Liangyu Pan; Tiansheng Li; Rui Wang; Weiheng Deng; Huangsheng Pu; Meichun Deng
Journal:  Cell Mol Neurobiol       Date:  2022-01-15       Impact factor: 5.046

Review 4.  The Emerging Roles of the Calcineurin-Nuclear Factor of Activated T-Lymphocytes Pathway in Nervous System Functions and Diseases.

Authors:  Maulilio John Kipanyula; Wahabu Hamisi Kimaro; Paul F Seke Etet
Journal:  J Aging Res       Date:  2016-08-15

5.  The Role of Dopamine D1 and D3 Receptors in N-Methyl-D-Aspartate (NMDA)/GlycineB Site-Regulated Complex Cognitive Behaviors following Repeated Morphine Administration.

Authors:  Yunpeng Wang; Fangyuan Yin; Hao Guo; Jing Zhang; Peng Yan; Jianghua Lai
Journal:  Int J Neuropsychopharmacol       Date:  2017-07-01       Impact factor: 5.176

6.  Pharmacological Characterization of Orofacial Nociception in Female Rats Following Nitroglycerin Administration.

Authors:  Robert M Caudle; Stephanie L Caudle; Natalie D Flenor; Eric L Rohrs; John K Neubert
Journal:  Front Pharmacol       Date:  2020-12-03       Impact factor: 5.810

7.  A Conantokin Peptide Con-T[M8Q] Inhibits Morphine Dependence with High Potency and Low Side Effects.

Authors:  Zhuguo Liu; Zheng Yu; Shuo Yu; Cui Zhu; Mingxin Dong; Wenxiang Mao; Jie Hu; Mary Prorok; Ruibin Su; Qiuyun Dai
Journal:  Mar Drugs       Date:  2021-01-19       Impact factor: 5.118

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.